Health Canada authorizes Tecentriq SC (atezolizumab, solution for subcutaneous injection), the first cancer ...
Subcutaneous (SC) injection offers an alternative administration option to intravenous (IV) infusion, with the opportunity to provide greater flexibility and convenience for patients, healthcare providers, and healthcare systems in how cancer treatment …